BCAR4, BCAR3 and EGFR Display Different Degrees of Cross-Resistance to Endocrine Mono- and Combination Therapies in Hormone Receptor Positive, HER2 Negative Breast Cancer
Breast Cancer: Targets and Therapy · 2026-11 · Volume 18 · 1-11
DOI: 10.2147/bctt.s604019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-11. Verfasst von Zhangzan Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands.
ORCID-Profile: Da-Wei Chan
Zitieren
APA
Huang, Z., Wortelboer, N., Beaufort, C. M., Ortak, S. N., Chan, D. W., Helmijr, J., Jager, A., Martens, J. W. M., & Jansen, M. P. H. M. (2026). BCAR4, BCAR3 and EGFR Display Different Degrees of Cross-Resistance to Endocrine Mono- and Combination Therapies in Hormone Receptor Positive, HER2 Negative Breast Cancer. Breast Cancer: Targets and Therapy, Volume 18, 1-11. https://doi.org/10.2147/bctt.s604019
Vancouver
Huang Z, Wortelboer N, Beaufort CM, Ortak SN, Chan DW, Helmijr J, et al. BCAR4, BCAR3 and EGFR Display Different Degrees of Cross-Resistance to Endocrine Mono- and Combination Therapies in Hormone Receptor Positive, HER2 Negative Breast Cancer. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-11. doi:10.2147/bctt.s604019
BibTeX
@article{Huang2026,
author = {Huang, Zhangzan and Wortelboer, Noor and Beaufort, Corine M and Ortak, Seda Nur and Chan, Da-Wei and Helmijr, Jean and Jager, Agnes and Martens, John W M and Jansen, Maurice P H M},
title = {BCAR4, BCAR3 and EGFR Display Different Degrees of Cross-Resistance to Endocrine Mono- and Combination Therapies in Hormone Receptor Positive, HER2 Negative Breast Cancer},
journal = {Breast Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 18},
pages = {1--11},
doi = {10.2147/bctt.s604019}
}
EUVIMED